Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Chinese products come with no guarantee. Tne countries that relied on Chinese Covid vaccines are now battling new virus surges.
According to a report in New York Times, countries like Mongolia, Seychelles and Bahrain that are vaccinating their population with Covid-19 vaccines made by China are now battling a surge in infections.
In Seychelles, Chile, Bahrain and Mongolia, about 50 to 68% of the populations have been fully inoculated with Chinese vaccines. However, they are also among the top 10 countries with the worst Covid-19 outbreaks, the NYT report said.
While the Pfizer-BioNTech and Moderna vaccines have efficacy rates of more than 90%, China's Sinopharm vaccine has an efficacy rate of 78.% and the Sinovac vaccine has an efficacy rate of 51%.

Countries giving Chinese Covid shots battle virus surge: NYT report

Tne countries that relied on Chinese Covid vaccines are now battling new virus surges, says NYT&nbsp;report

Countries giving Chinese Covid shots battle virus surge: report

Chinese products come with no guarantee. Tne countries that relied on Chinese Covid vaccines are now battling new virus surges.
According to a report in New York Times, countries like Mongolia, Seychelles and Bahrain that are vaccinating their population with Covid-19 vaccines made by China are now battling a surge in infections.
In Seychelles, Chile, Bahrain and Mongolia, about 50 to 68% of the populations have been fully inoculated with Chinese vaccines. However, they are also among the top 10 countries with the worst Covid-19 outbreaks, the NYT report said.
While the Pfizer-BioNTech and Moderna vaccines have efficacy rates of more than 90%, China's Sinopharm vaccine has an efficacy rate of 78% and the Sinovac vaccine has an efficacy rate of 51%.

Chinese products come with no guarantee. Tne countries that relied on Chinese Covid vaccines are now battling new virus surges.
According to a report in New York Times, countries like Mongolia, Seychelles and Bahrain that are vaccinating their population with Covid-19 vaccines made by China are now battling a surge in infections.
In Seychelles, Chile, Bahrain and Mongolia, about 50 to 68% of the populations have been fully inoculated with Chinese vaccines. However, they are also among the top 10 countries with the worst Covid-19 outbreaks, the NYT report said.
While the Pfizer-BioNTech and Moderna vaccines have efficacy rates of more than 90%, China's Sinopharm vaccine has an efficacy rate of 78.% and the Sinovac vaccine has an efficacy rate of 51%.

The World Health Organization on Friday approved the Sinopharm Covid-19 vaccine for emergency use, paving the way for poorer nations to get more vaccines that can help tackle the pandemic.
Sinopharm's vaccine is also the first Chinese jab to receive the WHO's approval. The UN health agency signed off on the two-dose vaccine, which is already being deployed in dozens of countries around the world. Besides China, it is being used in Algeria, Cameroon, Egypt, Hungary, Iraq, Iran, Pakistan, Peru, the United Arab Emirates, Serbia and Seychelles, among others.
An emergency use approval by the WHO means the vaccine can be included in Covax, the World Health Organization&rsquo;s global initiative that is designed to promote equitable vaccine distribution around the world.
Though the Sinopharm vaccine is already in widespread use around the world with an estimated 65 million doses administered, its developers have released only limited information about the vaccine&rsquo;s efficiency and side effects.

WHO approves China's Sinopharm Covid-19 vaccine for emergency use

WHO approves&nbsp;Sinopharm's Covid-19 vaccine for emergency use, first Chinese vaccine to get WHO approval

WHO approves China-made&nbsp;Sinopharm's&nbsp;Covid&nbsp;vaccine
Moves allows poorer nations to get access to more vaccines
Sinopharm&nbsp;vaccine first Chinese jab to receive WHO&nbsp;approval
Vaccine already being deployed in several&nbsp;countries worldwide
In use in Algeria, UAE, Egypt, Hungary, Iraq, Iran, Pakistan
With WHO approval, vaccine can now be included in COVAX
An&nbsp;estimated 65 mn doses of&nbsp;Sinopharm&nbsp;vaccine&nbsp;administered

The World Health Organization on Friday approved the Sinopharm Covid-19 vaccine for emergency use, paving the way for poorer nations to get more vaccines that can help tackle the pandemic.
Sinopharm's vaccine is also the first Chinese jab to receive the WHO's approval. The UN health agency signed off on the two-dose vaccine, which is already being deployed in dozens of countries around the world. Besides China, it is being used in Algeria, Cameroon, Egypt, Hungary, Iraq, Iran, Pakistan, Peru, the United Arab Emirates, Serbia and Seychelles, among others.
An emergency use approval by the WHO means the vaccine can be included in Covax, the World Health Organization&rsquo;s global initiative that is designed to promote equitable vaccine distribution around the world.
Though the Sinopharm vaccine is already in widespread use around the world with an estimated 65 million doses administered, its developers have released only limited information about the vaccine&rsquo;s efficiency and side effects.

sinopharm

Categories